Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ib With Expansion of Patients at the MTD Study of Olaparib Plus Weekly (Metronomic) Carboplatin and Paclitaxel in Relapsed Ovarian Cancer Patients

NCT01650376 is registered in ClinicalTrials.gov with Swedish Medical Center as lead sponsor.

NCT NCT01650376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01650376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ib With Expansion of Patients at the MTD Study of Olaparib Plus Weekly (Metronomic) Carboplatin and Paclitaxel in Relapsed Ovarian Cancer Patients
Lead sponsor
Swedish Medical Center
Phase
Phase 1/2
Overall status
Unknown status
Start date
August 31, 2012
Completion date
December 31, 2019
Enrollment
52 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

stage iii ovarian cancer, stage iv ovarian cancer, uterine cancer